Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Biogaia Adr Class B BIOGY

Healthcare Biotechnology

Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics... see more

Add To Watchlist

Recent & Breaking News (PINL:BIOGY)

American Diabetes Association Announces New National Officers and Board Members

PR Newswire January 5, 2015

Evolution Fresh Offers Four Cold-Pressed Green Juices Made from More Than a Pound of Vegetables

Business Wire January 5, 2015

Lycera Scientists Identify Endogenous Agonists For RORgamma That Control Th17 Cell Differentiation

PR Newswire January 5, 2015

Klick Health Intranet Named One of World's Top 10 for 2015

Business Wire January 5, 2015

Recombine Inc. to Participate in the Fertility 2015 Conference

Business Wire January 5, 2015

NeoStem Strengthens Executive Management With Appointments of David J. Mazzo, PhD as Chief Executive Officer and Robert S. Vaters as President and Chief Financial Officer and Elects Robin Smith, MD to Executive Chair of the Board

GlobeNewswire January 5, 2015

WeMo® Further Expands Internet of Things Ecosystem with New Home Sensors

Business Wire January 5, 2015

Fluidigm to Present at the 33rd Annual J.P. Morgan Healthcare Conference

Business Wire January 5, 2015

Sorrento To Present At The 2015 Biotech Showcase And 8th Annual OneMedForum In San Francisco

PR Newswire January 5, 2015

Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies

PR Newswire January 5, 2015

IMBRUVICA® (ibrutinib) Data Demonstrates Efficacy in Previously Untreated and Relapsed/Refractory High-Risk Chronic Lymphocytic Leukemia Patients

PR Newswire January 5, 2015

Aldeyra Therapeutics Submits IND Filing to FDA for Clinical Testing of NS2 in Patients With Sjogren-Larsson Syndrome

GlobeNewswire January 5, 2015

Immunomedics Awarded Fast Track Designation by FDA for Sacituzumab Govitecan (IMMU-132) for Triple-Negative Breast Cancer Therapy

GlobeNewswire January 5, 2015

Alzheon Appoints David Nikodem, Ph.D., to Board of Directors

Business Wire January 5, 2015

Halozyme Therapeutics Appoints Athena Countouriotis, M.D. as Chief Medical Officer

PR Newswire January 5, 2015

BrainStorm Announces Final Analysis of Phase 2a ALS Study Showing Nearly All Subjects Experienced Clinical Benefit from NurOwn(TM)

PR Newswire January 5, 2015

CareDx Appoints John J. Sninsky, Ph.D. as Chief Scientific Officer

GlobeNewswire January 5, 2015

Cell MedX Corp. (CMXC) Announces Commencement of the Pilot Trial of Its e-balance Technology

Marketwired January 5, 2015

Interleukin's PerioPredict® Genetic Test Featured in Genome Magazine

Business Wire January 5, 2015

Cepheid Announces CFO Change

PR Newswire January 5, 2015